Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
4m agoMesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain
5m agoSyntec Optics (Nasdaq: OPTX) Announces Pricing of $20 Million Underwritten Public Offering of Common Stock
5m agoWoodside Energy First Quarter Report for Period Ended 31 March 2026
5m agoInnoCare Announces First Patient Dosed in Phase III Trial of Orelabrutinib for SLE
32m agoJyong Biotech Updates Market Access Strategy for Innovative Botanical Drugs, Establishing Multiple Competitive Advantages for New Drug Portfolio

Dr. Martens Plc

About

Dr. Martens Plc (LSE:DOCS) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 8 2026
Appointment of Market General Managers
Feb 27 2026
Total Voting Rights
Jan 29 2026
EBT Share Purchase
Jan 27 2026
Holding(s) in Company
Jan 27 2026
Q3 FY26 Trading Statement

Financials

Revenue
GBX785 M
Market Cap
GBX620.65 M
P/E Ratio
32.10
EPS
0.02
Dividend Yield
4.09%

Community Chat

Ask AI

6ix6ixAIEvents